The response and survival rates of Y-90 radioembolization in patients with unresectable liver tumors; a single-centre experience

被引：0
|
作者：
Ekmekcioglu, O. [1 ]
Tabakci, O. [2 ]
Simsek, D. Has [1 ]
Bayrak, A. Hasanefendioglu [2 ]
Bilgic, S. [3 ]
Berk, G. [1 ]
Simsek, C. [1 ]
Kaplan, N. [4 ]
Battal, M. [5 ]
机构：
[1] Sisli Etfal Educ & Res Hosp, Dept Nucl Med, Istanbul, Turkey
[2] Sisli Etfal Educ & Res Hosp, Intervent Radiol Dept, Istanbul, Turkey
[3] Cerrahpasa Med Fac, Dept Nucl Med, Istanbul, Turkey
[4] Sisli Etfal Educ & Res Hosp, Dept Med Oncol, Istanbul, Turkey
[5] Sisli Etfal Educ & Res Hosp, Gen & Hepatobiliary Surg Dept, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-125
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Incidence of Kidney Injury Post Y-90 Radioembolization: A Single Centre Experience
    Peh, W.
    Khor, Y.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S802 - S802
  • [2] Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
    Tsang, Erica S.
    Loree, Jonathan M.
    Davies, Janine M.
    Gill, Sharlene
    Liu, David
    Ho, Stephen
    Renouf, Daniel J.
    Lim, Howard J.
    Kennecke, Hagen F.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [3] Treatment of unresectable neuroendocrine liver tumors with Y-90 microsphere: Ankara University experience
    Kucuk, O.
    Lacin, S.
    Yagci, S.
    Oz, I.
    Bilgic, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S350 - S350
  • [4] Treatment of Unresectable Neuroendocrine Liver Tumors with Y-90 Microsphere
    Kucuk, O.
    Lacin, S.
    Oz, I
    Bilgic, S.
    [J]. NEUROENDOCRINOLOGY, 2010, 92 (01) : 42 - 42
  • [5] Efficacy and prognostic factors for y-90 radioembolization (Y-90) in metastatic neuroendocrine tumors with liver metastases.
    Tsang, Erica S.
    Loree, Jonathan M.
    Davies, Janine Marie
    Gill, Sharlene
    Liu, David
    Ho, Stephen
    Kennecke, Hagen F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Y-90 Radioembolization of Liver Metastases from Neuroendocrine (NET) Tumors
    Bongini, M.
    Coppa, J.
    Spreafico, C.
    Virdis, M.
    Monteleone, M.
    Chiesa, C.
    Vaiani, M.
    Cascella, T.
    Bhoori, S.
    Flores, M.
    Mazzaferro, V
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 238 - 238
  • [7] Intra-arterial radioembolization with Y-90 for unresectable primary and metastatic liver tumors and evaluation of treatment response by FDG PET/CT
    Kucuk, O. N.
    Soydal, C.
    Lacin, S.
    Ozkan, E.
    Araz, M.
    Ibis, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S371 - S372
  • [8] YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy
    Gunduz, S.
    Ozgur, O.
    Bozcuk, H.
    Coskun, H. S.
    Ozdogan, M.
    Erkilic, M.
    Sindel, T.
    Yildiz, A.
    Yilmaz, S.
    Savas, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S604 - S604
  • [9] Yttrium-90 (Y-90) Radioembolization for Colorectal Cancer (CRC) Liver Metastases: A Single Institution Experience
    Nace, G. W.
    Steel, J. L.
    Gamblin, T. C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 89 - 90
  • [10] Survival outcomes for transarterial Y-90 radioembolization with glass microspheres in hepatocellular carcinoma patients: a single-institution experience
    Kappadath, S. C.
    Mahvash, A.
    Long, J.
    Abdelsalam, M.
    Avritscher, R.
    Chasen, B.
    Kaseb, A.
    Kuban, J.
    Murthy, R.
    Odisio, B.
    Teyateeti, A.
    Macapinlac, H.
    Teyateeti, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S257 - S257
12345